Status:

COMPLETED

A Prospective Single Center Clinical Study for Capsulotomy Using the LenSx 550 Laser

Lead Sponsor:

LenSx Lasers Inc.

Conditions:

Cataract

Eligibility:

All Genders

24+ years

Phase:

NA

Brief Summary

The LenSx 550 laser system is a femtosecond laser intended for use in performing anterior capsulotomy during cataract surgery. The anterior capsulotomy creates a circular opening in the anterior surfa...

Eligibility Criteria

Inclusion

  • Must be eligible to undergo cataract extraction by phacoemulsification with primary intraocular lens implantation in at least 1 eye.
  • Must be at least 24 years of age.
  • Must be willing and able to return for scheduled follow-up examinations.
  • Subjects must sign and be given a copy of the written Informed Consent form.

Exclusion

  • Corneal disease or pathology that precludes applanation of the cornea or transmission of laser wavelength or distortion of laser light.
  • Subjects with a poorly dilating pupil or other defect of the pupil that prevents the iris from adequate retraction peripherally are excluded.
  • Subjects with residual, recurrent, active ocular or eyelid disease, including any corneal abnormality (for example, recurrent corneal erosion, severe basement membrane disease) in either eye are excluded.
  • History of steroid-responsive rise in intraocular pressure, glaucoma, or preoperative IOP\>21 mm Hg in either eye.
  • Lens/zonular instability such as, but not restricted to, Marfan's Syndrome, Pseudoexfoliation Syndrome, etc.
  • Previous intraocular or corneal surgery of any kind, including any type of surgery for either refractive or therapeutic purposes in either eye.
  • Subjects who are pregnant, lactating, or planning to be pregnant during the course of the study.
  • Known sensitivity to planned study concomitant medications.
  • Subjects participating in any other ophthalmic drug or device clinical trial during the time of this clinical investigation.
  • Subjects presenting any contraindications to cataract surgery.

Key Trial Info

Start Date :

August 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2009

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT00959322

Start Date

August 1 2008

End Date

March 1 2009

Last Update

October 14 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Semmelweis University

Budapest, Hungary, 1085